These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10679990)

  • 41. The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm.
    Than ME; Helm M; Simpson DJ; Lottspeich F; Huber R; Gietl C
    J Mol Biol; 2004 Mar; 336(5):1103-16. PubMed ID: 15037072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solvent effects on the conformation of cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu-). An NMR spectroscopy and molecular modeling study.
    Gonnella NC; Zhang X; Jin Y; Prakash O; Paris CG; Kolossváry I; Guida WC; Bohacek RS; Vlattas I; Sytwu T
    Int J Pept Protein Res; 1994 May; 43(5):454-62. PubMed ID: 8070969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Empirical rules predicting conformation of cyclic tetrapeptides from primary structure.
    Kato T; Lee S; Shimohigashi Y; Tone A; Kodera Y; Izumiya N
    Int J Pept Protein Res; 1987 Jan; 29(1):53-61. PubMed ID: 3570655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and solution conformation of c(D-Trp-D-Cys(SO3-Na+)-Pro-D-Val-Leu), a potent endothelin-A receptor antagonist.
    Bogusky MJ; Brady SF; Sisko JT; Nutt RF; Smith GM
    Int J Pept Protein Res; 1993 Aug; 42(2):194-203. PubMed ID: 8407113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MS(n) characterization of protonated cyclic peptides and metal complexes.
    Williams SM; Brodbelt JS
    J Am Soc Mass Spectrom; 2004 Jul; 15(7):1039-54. PubMed ID: 15234363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solution conformational dynamics of the C-terminal residues in endothelin-1 and some analogues: a time-resolved fluorescence study.
    Cowley DJ; Pelton JT
    Int J Pept Protein Res; 1995 Jul; 46(1):56-64. PubMed ID: 7558597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro assessment of oral delivery for hexapeptide endothelin antagonists.
    Stewart BH; Reyner EL; Tse E; Hayes RN; Werness S; He JX; Cody WL; Doherty AM
    Life Sci; 1996; 58(12):971-82. PubMed ID: 8786709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The interaction of analogues of the antimicrobial lipopeptide, iturin A2, with alkali metal ions.
    Rautenbach M; Swart P; van der Merwe MJ
    Bioorg Med Chem; 2000 Nov; 8(11):2539-48. PubMed ID: 11092539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aselacins, novel compounds that inhibit binding of endothelin to its receptor. II. Isolation and elucidation of structures.
    Hochlowski JE; Hill P; Whittern DN; Scherr MH; Rasmussen RR; Dorwin SA; McAlpine JB
    J Antibiot (Tokyo); 1994 May; 47(5):528-35. PubMed ID: 8040049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro stability and intestinal absorption characteristics of hexapeptide endothelin receptor antagonists.
    Han HK; Stewart BH; Doherty AM; Cody WL; Amidon GL
    Life Sci; 1998; 63(18):1599-609. PubMed ID: 9806213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of angiotensin peptides and zinc metal ions probed by electrospray ionization mass spectrometry.
    Loo JA; Hu P; Smith RD
    J Am Soc Mass Spectrom; 1994 Nov; 5(11):959-65. PubMed ID: 24226385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A nomenclature system for labeling cyclic peptide fragments.
    Ngoka LC; Gross ML
    J Am Soc Mass Spectrom; 1999 Apr; 10(4):360-3. PubMed ID: 10197354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigations of the mechanism of the "proline effect" in tandem mass spectrometry experiments: the "pipecolic acid effect".
    Raulfs MD; Breci L; Bernier M; Hamdy OM; Janiga A; Wysocki V; Poutsma JC
    J Am Soc Mass Spectrom; 2014 Oct; 25(10):1705-15. PubMed ID: 25078156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective ion binding and membrane activity of synthetic cyclopeptides.
    Gisin BF; Ting-Beall HP; Davis DG; Grell E; Tosteson DC
    Biochim Biophys Acta; 1978 May; 509(2):201-17. PubMed ID: 656410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gas phase studies of the interactions of Fe2+ with cysteine-containing peptides.
    Nemirovskiy OV; Gross ML
    J Am Soc Mass Spectrom; 1998 Dec; 9(12):1285-92. PubMed ID: 9835073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and structure-activity relationship studies of new endothelin pseudopeptide analogues containing alkyl spacers.
    Galoppini C; Giusti L; Macchia M; Hamdan M; Mazzoni MR; Calvani F; Rovero P
    Farmaco; 1999 Apr; 54(4):213-7. PubMed ID: 10384713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel D-leucine-containing Conus peptide: diverse conformational dynamics in the contryphan family.
    Jacobsen RB; Jimenez EC; De la Cruz RG; Gray WR; Cruz LJ; Olivera BM
    J Pept Res; 1999 Aug; 54(2):93-9. PubMed ID: 10461743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ascidiacyclamides containing oxazoline and thiazole motifs assume square conformations and show high cytotoxicity.
    Asano A; Yamada T; Taniguchi T; Sasaki M; Yoza K; Doi M
    J Pept Sci; 2018 Oct; 24(10):e3120. PubMed ID: 30221432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal structure of peptide cyclo-(D-Val-L-Pro-L-Val-D-Pro).
    Hamilton JA; Sabesan MN; Gisin BF; Steinrauf LK
    Biochem Biophys Res Commun; 1978 Feb; 80(4):949-54. PubMed ID: 637880
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis and DNA nicking studies of a novel cyclic peptide: cyclo[Lys-Trp-Lys-Ahx-].
    Cheng CT; Lo V; Chen J; Chen WC; Lin CY; Lin HC; Yang CH; Sheh L
    Bioorg Med Chem; 2001 Jun; 9(6):1493-8. PubMed ID: 11408167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.